Scleroderma-like Syndrome in the Setting of Pembrolizumab Therapy for Non-Small Cell Lung Cancer: Diagnosis and Dermatologic Management
Immune checkpoint inhibitors play an important role in the treatment of malignancies. ICIs consist of monoclonal antibodies directed against inhibitory immune receptors cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1), or programmed cell death-ligand 1 (PD-L1). PD-1 is a rec...
Saved in:
Main Authors: | Davide Fattore (Author), Teresa Battista (Author), Mario De Lucia (Author), Maria Carmela Annunziata (Author), Gabriella Fabbrocini (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
by: Amparo Burgos-San José, et al.
Published: (2021) -
Pembrolizumab-Induced Lichen Planus on the Scalp of a Patient with Non-Small-Cell Lung Carcinoma
by: Aya Yamashita, et al.
Published: (2021) -
Carcinoid Syndrome-Induced Scleroderma-Like Disease
by: Karen Koch, et al.
Published: (2019) -
DIFFERENTIAL DIAGNOSIS IN JUVENILE SCLERODERMA
by: M.K. Osminina, et al.
Published: (2008) -
DIFFERENTIAL DIAGNOSIS IN JUVENILE SCLERODERMA
by: M.K. Osminina, et al.
Published: (2008)